Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial (Q34231219)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

phase III clinical trial

0 references

0 references

Huntington's disease

0 references

0 references

object named as

Ralf Reilmann

4

0 references

object named as

Anne Rosser

5

0 references

Ferdinando Squitieri

object named as

Ferdinando Squitieri

3

0 references

Bernhard Landwehrmeyer

object named as

Bernhard Landwehrmeyer

2

0 references

object named as

Carsten Saft

7

0 references

Roger A. Barker

object named as

Roger A Barker

6

0 references

author name string

Justo Garcia de Yebenes

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Markus K Magnet

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Alastair Sword

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Asa Rembratt

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Joakim Tedroff

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

MermaiHD study investigators

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

7 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1049-1057

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalamic metabolism and symptom onset in preclinical Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A quantitative investigation of the substantia nigra in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Huntington's disease: clinical correlates of disability and progression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Huntington's disease out of the closet?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Uncovering the true prevalence of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dopamine and glutamate in Huntington's disease: A balancing act.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2(High) receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo pharmacology of the dopaminergic stabilizer pridopidine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Unified Huntington's disease rating scale: Reliability and consistency

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pallidal surgery for the treatment of primary generalized dystonia: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tetrabenazine treatment for Huntington's disease-associated chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rate of functional decline in Huntington's disease. Huntington Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970233-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(11)70233-2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34231219&oldid=1543558246"